ClinicalTrials.Veeva

Menu

Dapagliflozin Patient Satisfaction Survey

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Diabetes Mellitus, Type 2

Study type

Observational

Funder types

Industry

Identifiers

NCT02805283
D1690R00026

Details and patient eligibility

About

The purpose of this study is to evaluate the diabetes related treatment satisfaction for patients with type 2 diabetes mellitus

Full description

This is a cross-sectional, observational patient survey study. Study subjects will be adult commercial members of the large US health plan affiliated with Optum with evidence of T2D initiating dapagliflozin or a sulfonylurea medication within the 3 months prior to survey mailing.

Enrollment

653 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • At least one pharmacy claim for dapagliflozin or dapagliflozin/metformin ER in the most recent month of pharmacy data and no pharmacy claims for an SGLT2 medication during the 6 months prior to sample identification.
  • Evidence of T2D diagnosis.
  • Age ≥18 as of the drug index date.
  • 6 months of continuous enrollment in a commercial health plan with both pharmacy and medical benefits during the identification period through the patient interview sample identification date.
  • Self-reported T2D diagnosis during the patient interview.

Exclusion criteria

  • Patients with evidence of type 1 diabetes mellitus and unknown type
  • Patients who are pregnant

Trial design

653 participants in 2 patient groups

Dapagliflozin, dapagliflozin/met ER
Description:
Dapagliflozin cohort have at least one pharmacy claim for either dapagliflozin or dapagliflozin/metformin ER in the most recent month of pharmacy data and no pharmacy claims for a medication in the same drug class during the 6 months prior to sample identification.
Sulfonylurea
Description:
Sulfonylurea cohort have at least one pharmacy claim for sulfonylurea in the most recent month of pharmacy data and no pharmacy claims for a medication in the same drug class during the 6 months prior to sample identification.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems